Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preclinical and first clinical data reported for cancer candidate PQR-309

May 8, 2015

Specific Treg inhibition enhances antitumoral effect of DC vaccination in HCC

May 8, 2015

DHA derivative confers protection against neovascularization and retinopathy

May 7, 2015

NCX-667 reduces IOP in different animal models

May 7, 2015

A novel isoquinolone sulfonamide derivative for wet AMD

May 7, 2015

Replicor discloses phase II data for REP-2139

May 7, 2015

Anti-CD73 MAb enhances antitumor activity of anti-PD-1 treatment

May 6, 2015

Preliminary phase III results of Civacir to prevent HCV reinfection in liver transplant patients

May 6, 2015

Preclinical findings with ADC BAY-1187982 lead to clinical study

May 6, 2015

First preclinical data on Boehringer Ingelheim's novel MEK/Aurora kinase inhibitor

May 6, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...